Preclinical In Vitro and In Vivo Models for Adoptive Cell Therapy of Cancer
العنوان: | Preclinical In Vitro and In Vivo Models for Adoptive Cell Therapy of Cancer |
---|---|
المؤلفون: | Garima, Kaushik, Shivaprasad, Venkatesha, Bhavna, Verma, Bandana, Vishwakarma, Ai-Hong, Zhang, Amy, Wesa |
المصدر: | The Cancer Journal. 28:257-262 |
بيانات النشر: | Ovid Technologies (Wolters Kluwer Health), 2022. |
سنة النشر: | 2022 |
مصطلحات موضوعية: | Mice, Cancer Research, Oncology, Cell Line, Tumor, Neoplasms, T-Lymphocytes, Cell- and Tissue-Based Therapy, Receptors, Antigen, T-Cell, Animals, Humans, Immunotherapy, Adoptive |
الوصف: | Adoptive cellular therapies are making major strides in the treatment of cancer, both for hematologic and solid tumors. These cellular products include chimeric antigen receptor T cells and T-cell receptor-modified T cells, tumor-infiltrating lymphocytes, marrow-infiltrating T cells, natural killer cells as well as macrophage-based therapeutics. Advancement in genomics, computational biology, immunology, and cell therapy manufacturing has facilitated advancement of adoptive T cell therapies into the clinic, whereas clinical efficacy has driven Food and Drug Administration approvals. The growth of adoptive cellular therapy has, in turn, led to innovation in the preclinical models available, from ex vivo cell-based models to in vivo xenograft models of treatment. This review focuses on the development and application of in vitro models and in vivo models (cell line xenograft, humanized mice, and patient-derived xenograft models) that directly evaluate these human cellular products. |
تدمد: | 1540-336X 1528-9117 |
URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b65ffe821018afeadd2b12744f993f7c https://doi.org/10.1097/ppo.0000000000000609 |
رقم الأكسشن: | edsair.doi.dedup.....b65ffe821018afeadd2b12744f993f7c |
قاعدة البيانات: | OpenAIRE |
تدمد: | 1540336X 15289117 |
---|